MoonLake Immunotherapeutics
MLTX
$9.55-6.92%
End of day · as of Oct 17, 2026, 5:00 AM ET
Mkt cap
$1.41B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-1.81
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.04
Div yield
N/A
Sector
Healthcare
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
Use this MLTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MLTX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
MoonLake Immunotherapeutics (MLTX) is a biotechnology company in the Healthcare sector.
Latest cached MoonLake Immunotherapeutics (MLTX) net income for FY2025 was -$227.3M. Statements: https://lician.com/financials/mltx
MoonLake Immunotherapeutics (MLTX) market capitalization is $1.41B on the latest cached snapshot.
MoonLake Immunotherapeutics (MLTX) cached previous close $10.26; day range $9.41 – $10.34; volume 1,380,669. Session quote: https://lician.com/quote/mltx
MoonLake Immunotherapeutics (MLTX) latest cached earnings event is "MLTX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MLTX filing is 8-K · Sep 30, 2026. Filings: https://lician.com/sec/mltx